Glenn A.  Eisenberg net worth and biography

Glenn Eisenberg Biography and Net Worth

Glenn A. Eisenberg serves as Chief Financial Officer, Executive Vice President of the Company. Mr. Eisenberg received his Bachelor of Arts degree from Tulane University in 1982 and his Master of Business Administration from Georgia State University in 1988. From 2002 until joining the Company, he served as the Executive Vice President of Finance and Administration and Chief Financial Officer at The Timken Company, a $4.3 billion leading global manufacturer of highly engineered bearings and alloy steels and related products and services. Previously, he served as President and Chief Operating Officer of United Dominion Industries, now a subsidiary of SPX Corporation, after working in several roles in finance, including Executive Vice President and Chief Financial Officer. Mr. Eisenberg serves on the Board of Directors of US Ecology, Inc. (NASDAQ: ECOL) since December 2018, and as a director of Perspecta Inc. (NYSE: PRSP) since May 2019. Mr. Eisenberg served on the Boards of Directors of Family Dollar Stores Inc. until July 2015, where he chaired the Audit Committee; and Alpha Natural Resources Inc. until May 2015, where he was the lead independent director and chaired the Nominating and Corporate Governance Committee.

What is Glenn A. Eisenberg's net worth?

The estimated net worth of Glenn A. Eisenberg is at least $5.17 million as of February 21st, 2024. Mr. Eisenberg owns 23,595 shares of Laboratory Co. of America stock worth more than $5,171,080 as of February 26th. This net worth estimate does not reflect any other investments that Mr. Eisenberg may own. Additionally, Mr. Eisenberg receives an annual salary of $1,540,000.00 as CFO at Laboratory Co. of America. Learn More about Glenn A. Eisenberg's net worth.

How old is Glenn A. Eisenberg?

Mr. Eisenberg is currently 63 years old. There are 6 older executives and no younger executives at Laboratory Co. of America. The oldest executive at Laboratory Co. of America is Ms. Sandra D. van der Vaart, Executive VP, Chief Legal Officer, Chief Compliance Officer & Corporate Secretary, who is 64 years old. Learn More on Glenn A. Eisenberg's age.

What is Glenn A. Eisenberg's salary?

As the CFO of Laboratory Co. of America Holdings, Mr. Eisenberg earns $1,540,000.00 per year. The highest earning executive at Laboratory Co. of America is Mr. Adam H. Schechter, President, CEO & Chairman, who commands a salary of $3,720,000.00 per year. Learn More on Glenn A. Eisenberg's salary.

How do I contact Glenn A. Eisenberg?

The corporate mailing address for Mr. Eisenberg and other Laboratory Co. of America executives is 358 South Main Street, BURLINGTON NC, 27215. Laboratory Co. of America can also be reached via phone at (336) 229-1127 and via email at [email protected]. Learn More on Glenn A. Eisenberg's contact information.

Has Glenn A. Eisenberg been buying or selling shares of Laboratory Co. of America?

Within the last three months, Glenn A. Eisenberg has sold $7,451,828.88 of Laboratory Co. of America stock. Most recently, Glenn A. Eisenberg sold 34,504 shares of the business's stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $215.97, for a transaction totalling $7,451,828.88. Following the completion of the sale, the chief financial officer now directly owns 23,595 shares of the company's stock, valued at $5,095,812.15. Learn More on Glenn A. Eisenberg's trading history.

Who are Laboratory Co. of America's active insiders?

Laboratory Co. of America's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Brian Caveney (EVP), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Laboratory Co. of America's active insiders.

Are insiders buying or selling shares of Laboratory Co. of America?

During the last year, insiders at the medical research company sold shares 10 times. They sold a total of 51,793 shares worth more than $11,208,958.28. The most recent insider tranaction occured on February, 21st when CFO Glenn A Eisenberg sold 34,504 shares worth more than $7,451,828.88. Insiders at Laboratory Co. of America own 0.7% of the company. Learn More about insider trades at Laboratory Co. of America.

Information on this page was last updated on 2/21/2024.

Glenn A. Eisenberg Insider Trading History at Laboratory Co. of America

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/21/2024Sell34,504$215.97$7,451,828.8823,595View SEC Filing Icon  
9/26/2022Sell25,000$210.62$5,265,500.0027,158View SEC Filing Icon  
8/3/2022Sell32,100$253.94$8,151,474.0052,158View SEC Filing Icon  
7/8/2019Sell5,563$176.75$983,260.2517,059View SEC Filing Icon  
6/7/2019Sell10,000$167.40$1,674,000.0028,366View SEC Filing Icon  
5/30/2018Sell10,000$181.21$1,812,100.0018,843View SEC Filing Icon  
2/12/2018Sell8,400$167.36$1,405,824.0015,931View SEC Filing Icon  
8/1/2017Sell5,968$159.46$951,657.2818,122View SEC Filing Icon  
3/9/2017Sell2,300$142.47$327,681.0012,556View SEC Filing Icon  
8/4/2016Sell8,000$140.10$1,120,800.008,668View SEC Filing Icon  
See Full Table

Glenn A. Eisenberg Buying and Selling Activity at Laboratory Co. of America

This chart shows Glenn A Eisenberg's buying and selling at Laboratory Co. of America by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Laboratory Co. of America Company Overview

Laboratory Co. of America logo
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Read More

Today's Range

Now: $218.76
Low: $218.76
High: $219.27

50 Day Range

MA: $223.81
Low: $215.65
High: $232.56

2 Week Range

Now: $218.76
Low: $174.20
High: $234.09


15,946 shs

Average Volume

692,346 shs

Market Capitalization

$18.57 billion

P/E Ratio


Dividend Yield